Aurora Cannabis Q2 revenues surge as it captures 20 per cent of Canadian sales Cannabis, Life Science
Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China Life Science
Vitruvias Therapeutics Inc. Enters into a Semi-Solid (Topical) Licensing Agreement with Hong Kong-Based Bright Future Life Science